Golden
Qiagen

Qiagen

Qiagen is a biotechnology company providing sampling and assay technologies for molecular diagnostics and applied testing for use in the private and public sectors. The company is headquartered in Venlo, Netherlands and was founded in 1984 by Metin Colpan.

Qaigen is a biotechnology company headquartered in Venlo, Netherlands and founded by Metin Colpan in 1984. Qaigen is a publicly traded company on the New York Stock and Frankfurt Prime Standard exchanges. Qiagen has around 4,700 employees in over 35 locations in 25 countries around the world.

Qaigen supplies technologies that help private and public scientists perform molecular diagnostics and applied testing in their experiments and//or tests. Their products are used for research and testing in several industries which include: healthcare, veterinary practices, forensics, food safety, pharmaceutical, bioinformatics, biotechnology, and life science.

Timeline

November 29, 1984

Qiagen was founded.

People

Name
Role
LinkedIn

Abdul Muqeet

Employee

Ada Kim

Employee

Adam Abdool

Employee

Alexandra Lanicca

Employee

Alexandru-Valentin Pavelescu

Employee

Ali Murat Kaya

Employee

Alison Zartarian

Employee

Andy Wende

Employee

Angela Long

Employee

Anika Joecker

Employee

Anita Suresh

Employee

Anja Lykkebak

Employee

Annete Koch

Senior Vice President and Chief Human resources Officer

Anosheh Amery

Employee

ANTONELLA CAPIZZI ACC, Chartered-MCIPD, MA-HRM, MSSc

Employee

Anu Jayaraman

Employee

Arianna Morosetti

Employee

Attila Mihaly Balazs

Employee

Attila-Mihaly Balazs (Grey Panther)

Employee

Austin Waltz

Employee

SHOW MORE (153)

Further reading

Title
Author
Link
Type
Date

History of Qiagen N.V. - FundingUniverse

International Directory of Company Histories, Vol. 39. St. James Press, 2001.

Web

QIAGEN and NeuMoDx Announce Strategic Partnership to Offer Next-Generation Systems for Fully Integrated Molecular Diagnostic Testing

Business Wire

Web

Qiagen launches molecular analysis panel for GI disorders in Europe

Medical Device Network

Web

Documentaries, videos and podcasts

Title
Date
Link
+ Add new row

Companies

Company
CEO
Location
Products/Services
+ Add new row

News

Title
Author
Date
Publisher
Description
October 15, 2019
WebWire
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced the launch of innovative new technologies for faster, simpler library preparation for next-generation sequencing (NGS) in the growing field of RNA research. QIAGEN is showcasing its industry-leading portfolio of universal NGS solutions at ASHG 2019, the annual meeting of the American Society of Human Genetics, from October 15-19 in Houston. Attendees will also get the chance to experience QIAGEN's new GeneGlobe Design & Analy...
May 17, 2019
WebWire
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and Inovio Pharmaceuticals Inc. (NASDAQ: INO) announced a collaboration to co-develop a companion diagnostic to guide clinical decision-making for the use of Inovio's DNA-based immunotherapy to treat cervical dysplasia caused by human papillomavirus (HPV). The Precision Medicine partnership focuses on Inovio's VGX-3100, a late-stage investigational product candidate with potential to become the first treatment for HPV infection...

References